Sun Pharmaceutical Industries Inc recalls DOXOrubin Hydrochloride Liposome injection
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Presence of Particulate matter: Particulate matter identified as glass.
- Products
-
- DOXOrubin Hydrochloride Liposome injection
- Where it was sold
-
U.S. Nationwide
Nationwide
- Units affected
- 675 vials
- About this recall
- DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, NDC 72603-200-01.